News Posts matching 'Aseptika'
Coronavirus: Helping GPs with vital signs monitoring at home supporting online and telephone consultations
GPs are now seeing just seven in every 100 patients face-to-face because of the coronavirus outbreak, following a marked shift to online and telephone appointments across England. Last year fewer than 1% of appointments were conducted by video link, and 80% were in person. Social distancing and the need to protect NHS staff has changed […]
Posted on April 16, 2020
Remote Care Support for Older People and the Most Vulnerable using Activ8rlives App
The UK has announced that older people (over 70 years of age) and the most vulnerable may soon need to self-isolate for up to four months. UK Company Aseptika is offering its Activ8rlives4 Health+Wellness App free-of-charge for families to provide remote support for older family members that have to self-isolate, which is also available via […]
Posted on March 17, 2020
Asthma Smart App (Asthma⁺me) used in primary care avoids presentation to Emergency Department for 6-year old with severe asthma
Paediatric asthma is an NHS Long-Term Plan priority and innovative approaches to managing the increasing number of children with moderate-to-severe asthma are needed.
Posted on March 3, 2020
Activ8rlives’ Asthma+me solution looking to expand to UAE and Saudi Arabia
Activ8rlives attending Arab Health looking to expand collaborations with hospitals specialising in childhood asthma.
Posted on January 14, 2020
National Public Health Award for Maxine and Sandwell Weigh2GO Weight Management Programme
A Sandwell Council employee has won a national award for her work in helping hundreds of people in the borough to lose weight. Maxine Dixon has won the UK Public Health Practitioner Award for Improving Public Health Practice for the council’s much-praised Weigh2GO programme. Maxine is a weight management project manager in Public Health at […]
Posted on December 5, 2019
Active+me programme and Activ8rlives App helps give NHS patients living with heart conditions the confidence and skills to exercise safely
More than 26,000 people are recorded as living with heart disease in Cambridge and Peterborough and regular activity is one of the best ways for people with a heart condition to make a good recovery after surgery or a heart attack, but patients are confused . What is safe? How much should they do? A […]
Posted on November 18, 2019
Asthma+me – the App being trialled to help children manage severe asthma
A new Asthma+me App is being trialled at Sheffield Children’s Hospital to help children manage their severe asthma. A partnership between Sheffield Children’s and technology company Aseptika, the innovative trial uses the newly developed Asthma+me App to help patient and parents better manage severe asthma outside of the hospital. The App allows the patient and/or […]
Posted on August 12, 2019
Asthma+me innovative technology-enabled solution for paediatric asthma is shortlisted for Best Technological Innovation: Digital
The Medtech Insight Awards 2019 have shortlisted Aseptika’s Asthma+me solution in the category of ‘Best Technological Innovation: Digital’. Asthma+me has been co-designed with a Paediatrician at an NHS Trust (UK) to support transition from treatment in a specialist paediatric clinics to community care, with the initial focus on meeting the needs of children aged 6-12 […]
Posted on August 9, 2019
Aseptika wins big at West Midlands healthcare innovation awards
Local Cambridgeshire healthcare company, Aseptika Ltd (Activ8rlives) has been awarded the Digital or Artificial Intelligence Innovation of the Year Award at the Meridian Awards – A Celebration of Innovation, for its ground-breaking Active+me patient activation programme. The Active+me programme combines group exercise classes, health coaching, peer support, PAM (Patient Activation Measure) monitoring, with Aseptika – […]
Posted on August 5, 2019
Novel medical-grade wearable patent granted to Aseptika for BuddyWOTCH
Aseptika Ltd announces that the European Patent Office has granted a patent for its medical-grade wearable, for use by patients with severe cardiovascular and respiratory diseases (EU patent number 3197354).
Posted on July 24, 2019